REQUEST A DEMO
Total
USD $0.00
Search more companies

Le-Mantus Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Le-Mantus Pharmaceuticals Private Limited Profile Updated: May 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Le-mantus Pharmaceuticals Private Limited is an unlisted company, incorporated on 24/01/2006. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24233DL2006PTC145303 and registration number is 145303. The company is a trade company, it is engaged in wholesale trading.

Legal Address
25 Shivam Apttssector 15 Rohini Delhi
Delhi; Delhi; Postal Code: 000000

Contact Details: Purchase the Le-Mantus Pharmaceuticals Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Le-Mantus Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Le-Mantus Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
January 24, 2006
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Ownership Details
Purchase this report to view the information.
81.8%
Purchase this report to view the information.
18.2%
Company Performance
Financial values in the chart are available after Le-Mantus Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
2.6%
Total operating revenue
2.6%
Operating profit (EBIT)
-23.09%
EBITDA
-20.45%
Net Profit (Loss) for the Period
-28.44%
Total assets
-12.74%
Total equity
25%
Operating Profit Margin (ROS)
-0.76%
Net Profit Margin
-0.69%
Return on Equity (ROE)
-14.93%
Debt to Equity Ratio
12.95%
Quick Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?